Nipro Corporation announces an Equity Buyback for 4,000,000 shares, representing 2.4% for ¥5,000 million.
July 03, 2018 at 02:00 am EDT
Share
Nipro Corporation (TSE:8086) announces a share repurchase program. Under the program, the company will repurchase up to 4,000,000 shares, representing 2.4% of its share capital, for ¥5,000 million. The company will repurchase its shares in order to enhance shareholder returns and improve capital efficiency. The share repurchase program will run until December 28, 2018. As of March 31, 2018, the company had 166,618,455 shares outstanding (excluding treasury shares) and 4,841,024 shares in treasury.
NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.
NIPRO CORPORATION 
